| 1. | | Suspended | 10-Propargyl-10-Deazaaminopterin in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma
Conditions: adult Hodgkin's lymphoma; adult non-Hodgkin's lymphoma |
| 2. | | No longer recruiting | 10-Propargyl-10-Deazaaminopterin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
Conditions: stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer; recurrent non-small cell lung cancer; Quality of Life |
| 3. | | Completed | 10-Propargyl-10-Deazaaminopterin Plus Probenecid in Treating Patients With Advanced Solid Tumors
Condition: unspecified adult solid tumor, protocol specific |
| 4. | | Recruiting | 17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors
Condition: Cancer |
| 5. | | Recruiting | 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic Kidney Cancer
Conditions: recurrent renal cell cancer; Stage IV Renal Cell Cancer; renal clear cell carcinoma |
| 6. | | Recruiting | 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Stage III or Stage IV Melanoma
Conditions: stage III melanoma; Stage IV Melanoma; Recurrent Melanoma |
| 7. | | Recruiting | 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid Tumors
Conditions: Ewing's family of tumors; childhood rhabdomyosarcoma; childhood soft tissue sarcoma; hematopoietic and lymphoid cancer; Neuroblastoma; Osteosarcoma |
| 8. | | Completed | 6-Hydroxymethylacylfulvene in Treating Patients With Metastatic Kidney Cancer
Conditions: Stage IV Renal Cell Cancer; recurrent renal cell cancer |
| 9. | | Completed | 6-Hydroxymethylacylfulvene in Treating Patients With Stage IVB or Recurrent Cervical Cancer
Conditions: recurrent cervical cancer; cervical adenocarcinoma; cervical squamous cell carcinoma; cervical adenosquamous cell carcinoma; ... |
| 10. | | Recruiting | ABI-007 in Treating Patients With Chemotherapy-Naïve Stage IV Non-Small Cell Lung Cancer
Conditions: stage IV non-small cell lung cancer; recurrent non-small cell lung cancer |
| 11. | | Recruiting | ABI-007, Carboplatin, and Trastuzumab in Treating Patients With HER2/neu-Overexpressing Metastatic Breast Cancer
Conditions: stage IV breast cancer; recurrent breast cancer |
| 12. | | Completed | Acupuncture and Acupressure in Treating Patients With Moderate or Severe Pain Related to Stage III or Stage IV Pancreatic Cancer
Conditions: stage III pancreatic cancer; recurrent pancreatic cancer; Pain; stage IVA pancreatic cancer; stage IVB pancreatic cancer |
| 13. | | Recruiting | Adjuvant Hepatic Arterial Infusion and Combination Chemotherapy in Treating Patients With Resectable Hepatic Metastases From Colorectal Cancer
Conditions: Colon Cancer; liver metastases; Rectal Cancer |
| 14. | | Recruiting | AG-013736 as Second-Line Therapy in Treating Patients With Metastatic Renal Cell (Kidney) Cancer
Conditions: recurrent renal cell cancer; Stage IV Renal Cell Cancer |
| 15. | | Recruiting | AG2037 in Treating Patients With Metastatic Cancer of the Colon or Rectum That Has Not Responded to Fluorouracil and Leucovorin
Conditions: recurrent colon cancer; stage IV colon cancer; recurrent rectal cancer; Stage IV rectal cancer; adenocarcinoma of the colon; ... |
| 16. | | Recruiting | Alanosine in Treating Patients With Cancer
Conditions: Gastrointestinal Cancer; musculoskeletal cancer; Osteosarcoma; thorax and respiratory cancer |
| 17. | | Completed | Amonafide in Treating Women With Metastatic Breast Cancer That Has Progressed After Previous Chemotherapy
Conditions: stage IV breast cancer; recurrent breast cancer |
| 18. | | Recruiting | Anal Sphincter Prosthesis in Treating Patients Who Are Undergoing Surgery for Anal or Rectal Cancer
Conditions: Anal Cancer; perioperative and postoperative complications; Rectal Cancer |
| 19. | | Recruiting | Arsenic Trioxide and Imatinib Mesylate in Treating Patients With Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Conditions: accelerated phase chronic myelogenous leukemia; blastic phase chronic myelogenous leukemia; recurrent adult acute lymphoblastic leukemia; ... |
| 20. | | Completed | Arsenic Trioxide in Treating Patients With Advanced Hematologic Cancer
Conditions: Leukemia; Lymphoma; Multiple Myeloma |
| 21. | | Recruiting | Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors
Condition: childhood cancer |
| 22. | | Completed | Arsenic Trioxide in Treating Patients With Advanced Solid Tumors
Conditions: unspecified childhood solid tumor, protocol specific; unspecified adult solid tumor, protocol specific |
| 23. | | Completed | Arsenic Trioxide in Treating Patients With Metastatic Kidney Cancer
Conditions: Stage IV Renal Cell Cancer; childhood kidney/urinary cancer; recurrent renal cell cancer |
| 24. | | Completed | Arsenic Trioxide in Treating Patients With Relapsed or Refractory Chronic Myelogenous Leukemia
Conditions: accelerated phase chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; refractory chronic myelogenous leukemia; ... |
| 25. | | Completed | Arsenic Trioxide in Treating Patients With Relapsed or Refractory Non- Hodgkin's Lymphoma
Conditions: recurrent adult diffuse small cleaved cell lymphoma; recurrent adult lymphoblastic lymphoma; recurrent grade III follicular large cell lymphoma; ... |
| 26. | | Completed | Arsenic Trioxide in Treating Patients With Stage IVB or Recurrent Cervical Cancer
Conditions: recurrent cervical cancer; cervical squamous cell carcinoma; cervical adenocarcinoma; stage IVB cervical cancer |
| 27. | | No longer recruiting | BAY 43-9006 in Treating Patients With Advanced Inoperable Liver Cancer
Conditions: adult primary hepatocellular carcinoma; advanced adult primary liver cancer; localized unresectable adult primary liver cancer |
| 28. | | Recruiting | Beclomethasone Plus Prednisone in Treating Patients With Graft-Versus-Host Disease
Condition: Graft Versus Host Disease |
| 29. | | Recruiting | beta-Glucan and Monoclonal Antibody in Treating Patients With Metastatic Neuroblastoma
Conditions: disseminated neuroblastoma; recurrent neuroblastoma |
| 30. | | Recruiting | Beta-Glucan and Rituximab in Treating Young Patients With Relapsed or Progressive Lymphoma or Leukemia, or Lymphoproliferative Disorder Related to Donor Stem Cell Transplantation
Conditions: childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Leukemia; Lymphoma |
| 31. | | Recruiting | Bevacizumab and Cetuximab With or Without Irinotecan in Treating Patients With Irinotecan-Refractory Metastatic Colorectal Cancer
Conditions: stage IV colon cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer |
| 32. | | No longer recruiting | Bexarotene and Interferon alfa in Treating Patients With Cutaneous T-Cell Lymphoma
Conditions: stage I cutaneous T-cell lymphoma; stage II cutaneous T-cell lymphoma; stage III cutaneous T-cell lymphoma; stage IV cutaneous T-cell lymphoma; ... |
| 33. | | No longer recruiting | Bicalutamide and Goserelin in Treating Patients With Cancer of the Ovary, Fallopian Tube, or Peritoneum
Conditions: recurrent ovarian epithelial cancer; peritoneal cavity cancer; Fallopian Tube Cancer |
| 34. | | No longer recruiting | Biological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic Cancer
Conditions: Leukemia; Lymphoma |
| 35. | | Recruiting | Biological Therapy in Treating Patients With Lymphoma or Lymphoproliferative Disease
Conditions: childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Leukemia; Lymphoma |
| 36. | | Recruiting | Biological Therapy in Treating Patients With Neuroblastoma That Has Not Responded to Previous Treatment
Conditions: localized unresectable neuroblastoma; disseminated neuroblastoma; regional neuroblastoma; stage 4S neuroblastoma; recurrent neuroblastoma |
| 37. | | Completed | Biological Therapy in Treating Patients With Prostate Cancer
Condition: recurrent prostate cancer |
| 38. | | No longer recruiting | BMS-214662 in Treating Patients With Advanced Solid Tumors
Condition: unspecified adult solid tumor, protocol specific |
| 39. | | Recruiting | BMS-247550 and Gemcitabine in Treating Patients With Advanced Solid Tumors
Condition: unspecified adult solid tumor, protocol specific |
| 40. | | Completed | BMS-247550 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy
Condition: unspecified adult solid tumor, protocol specific |
| 41. | | No longer recruiting | BMS-247550 in Treating Patients With Metastatic Stomach Cancer Previously Treated With Chemotherapy
Conditions: stage IV esophageal cancer; Adenocarcinoma of the Esophagus; recurrent gastric cancer; stage IV gastric cancer; recurrent esophageal cancer; ... |
| 42. | | Completed | BMS-247550 in Treating Patients With Recurrent Metastatic Stomach Cancer That Has Been Previously Treated With Chemotherapy
Conditions: stage IV esophageal cancer; Adenocarcinoma of the Esophagus; recurrent gastric cancer; stage IV gastric cancer; recurrent esophageal cancer; ... |
| 43. | | No longer recruiting | BMS-247550 in Treating Women With Metastatic Breast Cancer
Conditions: stage IV breast cancer; recurrent breast cancer |
| 44. | | No longer recruiting | BMS-247550 With or Without Estramustine in Treating Patients With Progressive Prostate Cancer
Conditions: adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer |
| 45. | | No longer recruiting | Bone Marrow Transplantation in Treating Patients With Acute Leukemia in First or Second Remission
Conditions: childhood acute myeloid leukemia in remission; adult acute lymphoblastic leukemia in remission; recurrent adult acute myeloid leukemia; ... |
| 46. | | Completed | Bortezomib and Carboplatin in Treating Patients With Recurrent or Progressive Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
Conditions: recurrent ovarian epithelial cancer; peritoneal cavity cancer; Fallopian Tube Cancer |
| 47. | | Suspended | Bortezomib in Treating Patients With Advanced or Metastatic Sarcoma
Conditions: adult soft tissue sarcoma; metastatic osteosarcoma; metastatic tumors of the Ewing's family; Osteosarcoma; tumors of the Ewing's family |
| 48. | | Recruiting | Bortezomib in Treating Patients With Lymphoproliferative Disorders
Conditions: adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia; indolent or aggressive adult non-Hodgkin's lymphoma |
| 49. | | Recruiting | Bortezomib in Treating Patients With Unresectable or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
Conditions: recurrent gastric cancer; stage III gastric cancer; stage IV gastric cancer; adenocarcinoma of the stomach |
| 50. | | Completed | Bryostatin 1 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
Conditions: stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity; stage IV squamous cell carcinoma of the lip and oral cavity; ... |
